財團法人生物技術開發中心 | Technology Promotion
Business > Technology Promotion
| No | Name | Type | Devt Phase /Application | Slide Deck |
| 1 | Development of Anti-CD73 Antibody for Cancer Immunotherapy | Biologics | Preclinical Testing | Review |
| 2 | Globo H-targeted CAR-T cells for solid tumor therapy | Biologics | Preclinical Testing | Review |
| 3 | PD-L1/TIM-3/CSF-1R antibody in preclinical studies for Cancer Immunotherapy | Biologics | Lead Discovery /Optimization | Review |
| 4 | Development of Novel ADC Targeted Neurotensin receptor-1 (NTSR1) for Head and Neck Cancer Therapy | ADC | Preclinical Testing | Review |
| 5 | UB-941: A Selective & Orally Active Raf Kinase Inhibitor as a Precision Medicine /Melanoma | Small Molecule | IND Ready | Review |
| 6 | Development of KRAS-degrader drugs against cancer | Small Molecule | Preclinical Testing | Review |
| 7 | Site-specific and Dual Payload Trimannosyl ADC Platform | Platform | Antibody, Protein, Peptide | Review |
| 8 | mRNA-LNP Development Platform | Platform | Nucleic Acid Drug | Review |
| 9 | DCB-Asset List & Current Pipeline | Review |